NCT00633438

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery

A Double-Blind, Placebo-Controlled, Randomized Comparison Study of the Efficacy of Celebrex 400 mg Single Dose Pre and Celebrex 200 mg Post Ambulatory Arthroscopic Knee Surgery for Total Analgesic Use After Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 204 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To compare total analgesic use at 24 hours after arthroscopic knee surgery in celecoxib-treated versus placebo-treated patients

Conditions

• Arthroscopy

Interventions

Type	Name	Description
OTHER	Placebo	Matched oral capsule administered 1 hour prior to surgery and matched oral capsule administered post surgery as needed
DRUG	Celecoxib	400 mg oral capsule as single dose administered 1 hour prior to surgery and 200 mg oral capsule as single dose administered post surgery as needed

Timeline

• Start date: 2004-01-01
• Completion: 2004-06-01
• First posted: 2008-03-12
• Last updated: 2021-02-21

Locations

18 sites across 1 country: United States